Amplification and Overexpression of SKP2 Are Associated with Metastasis of Non-Small-Cell Lung Cancers to Lymph Nodes
- 31 July 2004
- journal article
- Published by Elsevier in The American Journal of Pathology
- Vol. 165 (1), 175-180
- https://doi.org/10.1016/s0002-9440(10)63286-5
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Down‐regulation of SKP2 induces apoptosis in lung‐cancer cellsCancer Science, 2003
- Chromosomal imbalances in human lung cancerOncogene, 2002
- A Novel Target Gene, SKP2, within the 5p13 Amplicon That Is Frequently Detected in Small Cell Lung CancersThe American Journal of Pathology, 2002
- TFDP1, CUL4A, and CDC16 identified as targets for amplification at 13q34 in hepatocellular carcinomasHepatology, 2002
- S-Phase Kinase-Associated Protein 2 Expression in Non-Hodgkin's Lymphoma Inversely Correlates with p27 Expression and Defines Cells in S PhaseThe American Journal of Pathology, 2002
- PTEN regulates the ubiquitin-dependent degradation of the CDK inhibitor p27KIP1 through the ubiquitin E3 ligase SCFSKP2Current Biology, 2001
- How the Cyclin Became a Cyclin: Regulated Proteolysis in the Cell CycleCell, 1999
- Inhibition of Cell Migration, Spreading, and Focal Adhesions by Tumor Suppressor PTENScience, 1998
- DNA gains in 3q occur frequently in squamous cell carcinoma of the lung, but not in adenocarcinomaGenes, Chromosomes and Cancer, 1998
- pl9skp1 and p45skp2 are essential elements of the cyclin A-CDK2 S phase kinaseCell, 1995